NCT04811053View on ClinicalTrials.gov

HR021618 in Moderate to Severe Pain After Abdominal Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 12, 2021

Primary Completion Date

July 15, 2021

Study Completion Date

July 15, 2021

Conditions
Pain After Abdominal Surgery
Interventions
DRUG

HR021618

Treatment group A: HR021618 injection

DRUG

Placebo

Treatment group B: Saline injection

Trial Locations (1)

610041

West China Hospital, Sichuan University, Chengdu

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY